The Medicines Patent Pool - Five Years On
March 24, 2016
In the March edition of Pharmafocus magazine Carmela De Luca and Janice Calzavara discuss the benefits and draw backs of the The Medicines Patent Pool on the fifth anniversary of the program.
The Medicines Patent Pool (MPP) was founded five years ago as a program to improve access to affordable and appropriate human immunodeficiency virus (HIV) medicines in developing countries. During its relatively short existence, the program has negotiated licenses for 12 anti-retroviral (AVR) medications from seven different patent holders, sub-licenced these medications to 15 generic manufacturers, and expanded distribution to 117 countries.
Content shared on Bereskin & Parr’s website is for information purposes only. It should not be taken as legal or professional advice. To obtain such advice, please contact a Bereskin & Parr LLP professional. We will be pleased to help you.